Annual Shareholders Equity
-$2.59 M
-$5.64 M-185.18%
April 30, 2024
Summary
- As of February 8, 2025, ALZN annual stockholders equity is -$2.59 million, with the most recent change of -$5.64 million (-185.18%) on April 30, 2024.
- During the last 3 years, ALZN annual shareholders equity has fallen by -$4.61 million (-228.88%).
- ALZN annual shareholders equity is now -119.43% below its all-time high of $13.35 million, reached on April 30, 2022.
Performance
ALZN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.75 M
+$4.97 M+409.58%
October 31, 2024
Summary
- As of February 8, 2025, ALZN quarterly stockholders equity is $3.75 million, with the most recent change of +$4.97 million (+409.58%) on October 31, 2024.
- Over the past year, ALZN quarterly shareholders equity has increased by +$4.97 million (+409.58%).
- ALZN quarterly shareholders equity is now -75.54% below its all-time high of $15.34 million, reached on July 31, 2021.
Performance
ALZN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALZN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -185.2% | +409.6% |
| 3 y3 years | -228.9% | +409.6% |
| 5 y5 years | -918.6% | +409.6% |
ALZN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -119.4% | at low | -71.9% | +188.0% |
| 5 y | 5-year | -119.4% | at low | -75.5% | +188.0% |
| alltime | all time | -119.4% | at low | -75.5% | +188.0% |
Alzamend Neuro Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $3.75 M(-409.6%) |
| Jul 2024 | - | -$1.21 M(-53.3%) |
| Apr 2024 | -$2.59 M(-185.2%) | -$2.59 M(-39.2%) |
| Jan 2024 | - | -$4.26 M(+58.9%) |
| Oct 2023 | - | -$2.68 M(+2276.0%) |
| Jul 2023 | - | -$112.90 K(-103.7%) |
| Apr 2023 | $3.05 M | $3.05 M(-48.0%) |
| Jan 2023 | - | $5.86 M(-33.3%) |
| Oct 2022 | - | $8.79 M(-21.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2022 | - | $11.18 M(-16.3%) |
| Apr 2022 | $13.35 M(+563.3%) | $13.35 M(+11.6%) |
| Jan 2022 | - | $11.96 M(-8.2%) |
| Oct 2021 | - | $13.03 M(-15.1%) |
| Jul 2021 | - | $15.34 M(+662.3%) |
| Apr 2021 | $2.01 M(+145.0%) | $2.01 M(-255.3%) |
| Jan 2021 | - | -$1.30 M(-257.7%) |
| Apr 2020 | $821.70 K(+159.3%) | $821.70 K |
| Apr 2019 | $316.90 K | - |
FAQ
- What is Alzamend Neuro annual stockholders equity?
- What is the all time high annual shareholders equity for Alzamend Neuro?
- What is Alzamend Neuro annual shareholders equity year-on-year change?
- What is Alzamend Neuro quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Alzamend Neuro?
- What is Alzamend Neuro quarterly shareholders equity year-on-year change?
What is Alzamend Neuro annual stockholders equity?
The current annual shareholders equity of ALZN is -$2.59 M
What is the all time high annual shareholders equity for Alzamend Neuro?
Alzamend Neuro all-time high annual stockholders equity is $13.35 M
What is Alzamend Neuro annual shareholders equity year-on-year change?
Over the past year, ALZN annual stockholders equity has changed by -$5.64 M (-185.18%)
What is Alzamend Neuro quarterly stockholders equity?
The current quarterly shareholders equity of ALZN is $3.75 M
What is the all time high quarterly shareholders equity for Alzamend Neuro?
Alzamend Neuro all-time high quarterly stockholders equity is $15.34 M
What is Alzamend Neuro quarterly shareholders equity year-on-year change?
Over the past year, ALZN quarterly stockholders equity has changed by +$4.97 M (+409.58%)